Share Email Print

Proceedings Paper

Analysis of 18F-fluorodeoxy-glucose PET imaging data captured before and after Pc 4-mediated photodynamic therapy of U87 tumors in the athymic nude rat
Author(s): Nathan Cross; Davood Varghai M.D.; Chandra Spring-Robinson; Rahul Sharma; Raymond F. Muzic Jr.; Nancy L. Oleinick; D. Dean
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Introduction: Several workers have proposed the use of PET (Positron Emission Tomography) imaging for the outcome assessment of photodynamic therapy (PDT), especially for deep-seated tumors. We report on our study of 18Ffluorodeoxy- glucose (18F-FDG) PET imaging following brain tumor Pc4-PDT. Our working hypothesis was that the tumor's metabolic activity would decline dramatically following Pc 4-PDT owing to tumor necrosis. Methods: Seven days after intraparenchymal implantation of U87 cells, the brains of 12 athymic nude rats were imaged by micro-CT and/or micro-MR. These animals were also 18F-FDG micro-PET (&mgr;PET) scanned before and after Pc 4-PDT. 18F-FDG was used to trace metabolic activity that was monitored via &mgr;PET. Occurrence of PDT was confirmed on histology. The analysis of 18F-FDG dose and animal weight normalized &mgr;PET activity was studied over the 90 minute µPET scan. Results: Currently, &mgr;PET data have been studied for: (1) three of the animals that did not indicate tumor necrosis on histology and were assigned to a "Non-PDT" group, and (2) six animals that exhibited tumor necrosis on histology and were assigned to a "PDT" group. The &mgr;PET-detected 18F-FDG uptake activity in the tumor region before and after photoirradiation increased in the Non-PDT group an average of 2.28 times, and in the PDT group it increased an average of 1.15 times. Discussion: We are investigating the cause of the increase in 18F-FDG &mgr;PET activity that we observed in the PDT group. The methodology used in this study should be useful in determining whether this or other PET, SPECT, or MR functional imaging protocols will detect both the specificity and sensitivity of brain tumor necrosis following Pc 4-PDT.

Paper Details

Date Published: 23 March 2007
PDF: 8 pages
Proc. SPIE 6424, Photonic Therapeutics and Diagnostics III, 64242F (23 March 2007);
Show Author Affiliations
Nathan Cross, Case Western Reserve Univ. (United States)
Davood Varghai M.D., Case Western Reserve Univ. (United States)
Chandra Spring-Robinson, Case Western Reserve Univ. (United States)
Rahul Sharma, Case Western Reserve Univ. (United States)
Raymond F. Muzic Jr., Case Western Reserve Univ. (United States)
Nancy L. Oleinick, Case Western Reserve Univ. (United States)
D. Dean, Case Western Reserve Univ. (United States)

Published in SPIE Proceedings Vol. 6424:
Photonic Therapeutics and Diagnostics III
Henry Hirschberg M.D.; Brian Jet-Fei Wong M.D.; Reza S. Malek M.D.; Kenton W. Gregory M.D.; Nikiforos Kollias M.D.; Bernard Choi; Steen J. Madsen; Guillermo J. Tearney M.D.; Justus F. R. Ilgner M.D.; Haishan Zeng, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?